14/06/2016In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
19/05/2016Eczema affects around a fifth of children in the UK. Skin barrier impairment and dry skin are thought to be triggers of eczema in early life, partly through genetic predisposition. Environmental factors may also contribute to the breakdown of the skin barrier, including water hardness and chlorine in household water.
29/04/2016Researchers from the University of Washington's Department of Mechanical Engineering, in collaboration with partners from Gillette Children's Specialty Healthcare, have developed a new quantitative assessment of motor control in children with cerebral palsy called Walk-DMC, which could help predict which patients are -- or are not -- likely to benefit from such aggressive treatment.